In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

The free consultation period for this content is over.

It is now only available year-round to ESC Professional Members, Fellows of the ESC, and Young combined Members

The A body shape index and type 2 diabetes are mutually independent predictors of cardiovascular events in patients with peripheral artery disease

Session Poster Session 7

Speaker Christoph Saely

Event : ESC Congress 2018

  • Topic : preventive cardiology
  • Sub-topic : Prevention – Cardiovascular Risk Assessment: Scores
  • Session type : Poster Session

Authors : A Vonbank (Feldkirch,AT), CH Saely (Bern,CH), C Heinzle (Feldkirch,AT), D Zanolin (Feldkirch,AT), B Larcher (Feldkirch,AT), A Mader (Feldkirch,AT), A Leiherer (Triesen,LI), A Muendlein (Feldkirch,AT), H Drexel (Philadelphia,US)

A. Vonbank1 , C.H. Saely2 , C. Heinzle3 , D. Zanolin3 , B. Larcher1 , A. Mader1 , A. Leiherer4 , A. Muendlein3 , H. Drexel5 , 1Academic Teaching Hospital, Department of Medicine and Cardiology - Feldkirch - Austria , 2Bern University Hospital, Division of Angiology, Swiss Cardiovascular Center - Bern - Switzerland , 3VIVIT Institute - Feldkirch - Austria , 4Private University of the Principality of Liechtenstein - Triesen - Liechtenstein , 5Drexel University College of Medicine - Philadelphia - United States of America ,

European Heart Journal ( 2018 ) 39 ( Supplement ), 1295

Background: The A Body Shape index (ABSI) is calculated based on waist circumference, height and BMI and is a validated measure of visceral adiposity. In the general population, the ABSI has been shown to be an independent risk factor for premature mortality.

Purpose: The purpose of this study was to investigate the power of ABSI to predict cardiovascular events in patients with peripheral artery disease (PAD).

Methods: We prospectively recorded cardiovascular events in 319 patients with sonographically verified PAD over a mean follow-up time of 7.2±2.1 years.

Results: At baseline, the ABSI was significantly higher in patients with type 2 diabetes (T2DM) than in those who did not have diabetes (19.5±1.9 vs. 14.0±1.1; p<0.001). Prospectively, the ABSI significantly predicted the incidence of cardiovascular events (n=57) both univariately (standardized HR 1.36 [1.20–1.52]; p<0.001) and after adjustment for age, gender, smoking, LDL cholesterol, HDL cholesterol, hypertension and T2DM (standardized adjusted HR 1.17 [1.08–1.29]; p=0.010); also T2DM significantly predicted cardiovascular events in this fully adjusted model (adjusted HR 1.48 [1.25–1.74]; p<0.001).

Conclusion: We conclude that the ABSI and T2DM are mutually independent of cardiovascular events in patients with PAD.

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are